K. Kawase, K. Yoshida, K. Hara, S. Hidaka, and H. Takeyama, “Efficacy and safety of neoadjuvant chemotherapy with dose de-escalation tri-weekly nanoparticle albumin-bound paclitaxel and FEC for human epidermal growth factor receptor 2-positive breast cancer”, Clinical Medicine Insights, vol. 4, no. 2, pp. 378–386, Jun. 2023.